Prospective study on plasma clotting parameters in diabetic children--no evidence for specific changes in coagulation system

Exp Clin Endocrinol Diabetes. 2001;109(3):146-50. doi: 10.1055/s-2001-14837.

Abstract

In a prospective study, clotting parameters of 37 children and adolescents with insulin-dependent diabetes mellitus (type 1 diabetes) were compared with those of a healthy control group. In a longitudinal follow-up over two years we found no statistical difference for most of the coagulation parameters investigated, including single factor analysis and coagulation inhibitors. The duration of type 1 diabetes was of no influence on these parameters. The only difference we found between patients and healthy controls was an elevation of PAI-1 in diabetics: median for PAI-1: 2.12 IU/ml in diabetics (range 0.50-8.40 IU/ml) and 0.84 IU/ml in normal controls (range 0.50-1.78 IU/ml). This difference was of statistic significance (p < 0.002) and also found in newly diagnosed patients. During observation time, none of our patients developed thrombosis or signs of vascular disease. In conclusion, we could not confirm the development of a hyper-coagulable state in pediatric diabetics, as it is described for adults with type 1 diabetes mellitus.

MeSH terms

  • Adolescent
  • Antithrombin III / analysis
  • Blood Coagulation*
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / blood*
  • Fibrinogen / analysis
  • Humans
  • Infant
  • Partial Thromboplastin Time
  • Peptide Fragments / analysis
  • Peptide Hydrolases / analysis
  • Plasminogen Activator Inhibitor 1 / blood
  • Prospective Studies
  • Protein C / analysis
  • Protein S / analysis
  • Prothrombin / analysis
  • Prothrombin Time

Substances

  • Peptide Fragments
  • Plasminogen Activator Inhibitor 1
  • Protein C
  • Protein S
  • antithrombin III-protease complex
  • prothrombin fragment 1.2
  • Antithrombin III
  • Prothrombin
  • Fibrinogen
  • Peptide Hydrolases